跳至主要内容
临床试验/IRCT20201119049439N1
IRCT20201119049439N1招募中2 期

Eficacy of Intracavernosal Injections of 50 units versus 100 units Abo botulinum toxinA (Dysport®) in vasculogenic Erectile Dysfunction with Phosphosdiesterase Type 5 Inhibitors resistant

Ahvaz University of Medical Sciences0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40 years 至 70 years(—)
性别
Male

入选标准

  • 40 to 70 years of age
  • Erectile Dysfunction proved by colour doppler sonography
  • Failure to response to first lines treatments

排除标准

  • significant cardiovascular diseases that interfere with erectile function
  • History of unstable physical and psychological situations
  • Anatomical abnormalities of the penis
  • Hormonal disorders
  • History of spinal cord or pelvic radical surgery

研究者

相似试验